CRS: JHU
Position: Co-investigator
CRS: BJMC
Position: Dean, BJ Medical College and India CRS PI
Position: Study Coordinator
Position: CRS Leader
Position: CTU Leader for HPTN Studies
Position: Site Leader
Position: Global Community Advisory Board Representative
CRS: BJMCJHU
Position: Principal Investigator, Johns Hopkins Professor of Medicine and Public Health; Deputy Director, CCGHE
Position: CRS Data Manager and Deputy Director
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
